Edison has issued an update on Worldwide Healthcare Trust.
Edison says: “Worldwide Healthcare Trust (WWH) aims to generate long-term capital growth from investing in a portfolio of global healthcare stocks; a differentiating feature is the trust’s c 15% exposure to emerging markets. Following a change in mandate in 2010, WWH now invests in all sectors of the healthcare industry.
“Performance versus its benchmarks is particularly strong over three, five and 10 years. Sam Isaly has been lead manager since launch in 1995; he is co-founder of the world’s largest specialist healthcare investment company, OrbiMed Capital.
“Following the recent US election with a win for Trump rather than Clinton, who was very vocal on drug pricing, WWH’s share price has rallied (more strongly than the US healthcare sector). The current discount to cum-income NAV of 1.9% compares to a range of a 0.7% premium to a 13.0% discount over the last 12 months (average of 6.2%). It is also narrower than the average discounts of the last three, five and 10 years (range of 4.8% to 6.5%). Given WWH’s focus on capital growth rather than income, it has a modest dividend yield, currently 0.8%.”
The report is available at: https://www.edisoninvestmentresearch.com/research/report/worldwide-healthcare-trust113490/preview/?utm_source=edison&utm_medium=rns_reach&utm_campaign=worldwidehealthcaretrust_23112016
At 1:13pm: (LON:WWH) Worldwide Healthcare Trust PLC share price was -1p at 2119p
Story provided by StockMarketWire.com